Paper36976378
JAK/STAT signaling and cellular iron metabolism in hepatocellular carcinoma: therapeutic implications.
Rah B and 3 others. Clin Exp Med, 2023. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. JAK/STAT signaling and cellular iron metabolism in hepatocellular carcinoma: therapeutic implications. Papers, record 36976378. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36976378
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- JAK/STAT signaling and cellular iron metabolism in hepatocellular carcinoma: therapeutic implications.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Iron Overload | Major topic |
| Humans | |
| Signal Transduction | |
| Janus Kinases | |
| Iron | |
| STAT Transcription Factors |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 22010901118 | Research Institute of Medical & Health Sciences, University of Sharjah | PubMed | ||
| 2022-KHA-001 | King Hussein Cancer Foundation, Jordan | PubMed |
Source PubMed
References98
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32273976 | JAK/STAT signaling in hepatocellular carcinoma. | Hepat Oncol | 2020 | https://conductscience.org/library/papers/32273976 | PubMed |
| 2 | 32956413 | Adenomatous polyposis coli-binding protein end-binding 1 promotes hepatocellular carcinoma growth and metastasis. | PLoS One | 2020 | https://conductscience.org/library/papers/32956413 | PubMed |
| 3 | 26725301 | Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease. | Trends Biochem Sci | 2016 | https://conductscience.org/library/papers/26725301 | PubMed |
| 4 | 33925597 | On Iron Metabolism and Its Regulation. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33925597 | PubMed |
| 5 | 29522138 | Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial. | JAMA Oncol | 2018 | https://conductscience.org/library/papers/29522138 | PubMed |
| 6 | 20347012 | Nuclear ferritin: A new role for ferritin in cell biology. | Biochim Biophys Acta | 2010 | https://conductscience.org/library/papers/20347012 | PubMed |
| 7 | 25676869 | Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma. | Hepatol Res | 2015 | https://conductscience.org/library/papers/25676869 | PubMed |
| 8 | 33895185 | Effect of hepcidin antagonists on anemia during inflammatory disorders. | Pharmacol Ther | 2021 | https://conductscience.org/library/papers/33895185 | PubMed |
| 9 | 29167669 | Iron Induces Anti-tumor Activity in Tumor-Associated Macrophages. | Front Immunol | 2017 | https://conductscience.org/library/papers/29167669 | PubMed |
| 10 | 30578415 | Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map. | Nat Rev Cancer | 2019 | https://conductscience.org/library/papers/30578415 | PubMed |
| 11 | 34821176 | The mechanisms and therapeutic targets of ferroptosis in cancer. | Expert Opin Ther Targets | 2021 | https://conductscience.org/library/papers/34821176 | PubMed |
| 12 | 30061739 | Molecular therapies and precision medicine for hepatocellular carcinoma. | Nat Rev Clin Oncol | 2018 | https://conductscience.org/library/papers/30061739 | PubMed |
| 13 | 34373750 | Targeting iron metabolism in cancer therapy. | Theranostics | 2021 | https://conductscience.org/library/papers/34373750 | PubMed |
| 14 | 31936571 | Ferroptosis in Cancer Cell Biology. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/31936571 | PubMed |
| 15 | 32476555 | Estrogen-induced epigenetic silencing of FTH1 and TFRC genes reduces liver cancer cell growth and survival. | Epigenetics | 2020 | https://conductscience.org/library/papers/32476555 | PubMed |
| 16 | 35806270 | Iron, Neuroinflammation and Neurodegeneration. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35806270 | PubMed |
| 17 | 32067993 | Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs. | Cancer Lett | 2020 | https://conductscience.org/library/papers/32067993 | PubMed |
| 18 | 34755647 | Iron disorders and hepcidin. | Clin Chim Acta | 2021 | https://conductscience.org/library/papers/34755647 | PubMed |
| 19 | 31173262 | Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor. | Oncol Rep | 2019 | https://conductscience.org/library/papers/31173262 | PubMed |
| 20 | 30130469 | Iron and Cancer. | Annu Rev Nutr | 2018 | https://conductscience.org/library/papers/30130469 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42364008 | Exosomal LINC00323 accelerates angiogenesis through activating the MAPK and JAK-STAT pathways by stabilizing CDC5L in NSCLC. | Cell Oncol (Dordr) | 2026 | https://conductscience.org/library/papers/42364008 | PubMed |
| 42082970 | Nanocarrier-mediated targeting of NF-κB and JAK/STAT signaling pathways in hepatocellular carcinoma: mechanisms and therapeutic strategies. | J Exp Clin Cancer Res | 2026 | https://conductscience.org/library/papers/42082970 | PubMed |
| 42060013 | Unveiling the Intricate Dance: Signaling Pathways in Liver Cancer Metabolism and Immunity. | Curr Oncol Rep | 2026 | https://conductscience.org/library/papers/42060013 | PubMed |
| 41987273 | JAK/STAT signaling in liver disease: a therapeutic target or a context-dependent double-edged sword? | J Transl Med | 2026 | https://conductscience.org/library/papers/41987273 | PubMed |
| 41655180 | "Cytokine-Mediated tumor sensitization: mechanistic frameworks and therapeutic opportunities in cancer Immunotherapy". | Clin Exp Med | 2026 | https://conductscience.org/library/papers/41655180 | PubMed |
| 41452426 | Therapeutic potential of natural triterpenoids in liver cancer. | Med Oncol | 2025 | https://conductscience.org/library/papers/41452426 | PubMed |
| 41296440 | APOC2 Promotes Clear Cell Renal Cell Carcinoma Progression via Activation of the JAK-STAT Signaling Pathway. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41296440 | PubMed |
| 41140341 | Targeting ferroptosis as a therapeutic strategy for hepatotoxicity. | Toxicol Rep | 2025 | https://conductscience.org/library/papers/41140341 | PubMed |
| 41055645 | Modulation of hepcidin synthesis: the core link in the bi-directional relationship between iron and obesity. | Rev Endocr Metab Disord | 2026 | https://conductscience.org/library/papers/41055645 | PubMed |
| 40939292 | TIM-3 ameliorates host responses to Salmonella infection by controlling iron driven CD4+ T cell differentiation and interleukin-10 formation. | EBioMedicine | 2025 | https://conductscience.org/library/papers/40939292 | PubMed |
| 40822972 | Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway. | Open Life Sci | 2025 | https://conductscience.org/library/papers/40822972 | PubMed |
| 40420174 | Targeting inflammation in cancer therapy: from mechanistic insights to emerging therapeutic approaches. | J Transl Med | 2025 | https://conductscience.org/library/papers/40420174 | PubMed |
| 40298145 | Discovery and biological evaluation of a novel and highly potent JAK2 inhibitor for the treatment of triple negative breast cancer. | J Enzyme Inhib Med Chem | 2025 | https://conductscience.org/library/papers/40298145 | PubMed |
| 39881344 | Formin protein DAAM1 positively regulates PD-L1 expression via mediating the JAK1/STAT1 axis in pancreatic cancer. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/39881344 | PubMed |
| 39845897 | Butyrolactone I blocks the transition of acute kidney injury to chronic kidney disease in mice by targeting JAK1. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/39845897 | PubMed |
| 39093298 | Iron Chelator Deferiprone Restores Iron Homeostasis and Inhibits Retinal Neovascularization in Experimental Neovascular Age-Related Macular Degeneration. | Invest Ophthalmol Vis Sci | 2024 | https://conductscience.org/library/papers/39093298 | PubMed |
| 38625672 | Liver cancer wars: plant-derived polyphenols strike back. | Med Oncol | 2024 | https://conductscience.org/library/papers/38625672 | PubMed |
| 38602575 | Integrating iron metabolism-related gene signature to evaluate prognosis and immune infiltration in nasopharyngeal carcinoma. | Discov Oncol | 2024 | https://conductscience.org/library/papers/38602575 | PubMed |
| 38519710 | Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer. | Mol Cell Biochem | 2025 | https://conductscience.org/library/papers/38519710 | PubMed |
| 38375529 | Prognostic iron-metabolism signature robustly stratifies single-cell characteristics of hepatocellular carcinoma. | Comput Struct Biotechnol J | 2024 | https://conductscience.org/library/papers/38375529 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HAMP | 57817 | PubTator's text mining | https://conductscience.org/library/genes/57817 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36976378
GET https://conductscience.org/api/papers/v1/36976378/references?page=2